Search information pages
About Diagnostic Pathology
This page includes information about the aims and scope of Diagnostic Pathology, editorial policies, open access and article-processing charges, the peer review process and other information. For details of how to prepare and submit a manuscript through the online submission system, please see the instructions for authors.
Aims & scope
Diagnostic Pathology is an open access, peer-reviewed, online journal that considers research in surgical and clinical pathology, immunology, and biology, with a special focus on cutting-edge approaches in diagnostic pathology and tissue-based therapy.
Diagnostic Pathology covers all aspects of surgical pathology, including classic diagnostic pathology, prognosis-related diagnosis (tumor stages, prognosis markers, such as MIB-percentage, hormone receptors, etc.), and therapy-related findings. The journal will also focus on the technological aspects of pathology, including molecular biology techniques, morphometry aspects (stereology, DNA analysis, syntactic structure analysis), communication aspects (telecommunication, virtual microscopy, virtual pathology institutions, etc.), and electronic education and quality assurance (for example interactive publication, on-line references with automated updating, etc.).
These modern technologies occupy the field of pathology to a large extent, and tissue-based diagnosis is probably the most affected medical discipline. Diagnostic Pathology will provide an integrative journal for molecular pathology (biology) and digital pathology (virtual pathology), creating an open case discussion platform to be used during daily diagnostic work.
All articles published by Diagnostic Pathology are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.
Authors of articles published in Diagnostic Pathology are the copyright holders of their articles and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the article, according to the BioMed Central copyright and license agreement.
For authors who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.
Open access publishing is not without costs. Diagnostic Pathology therefore levies an article-processing charge of £1370/$2145/€1745 for each article accepted for publication. If the corresponding author's institution is a Member, the cost of the article-processing charge is covered by the membership, and no further charge is payable. In the case of authors whose institutions are Supporter Members, however, a discounted article-processing charge is payable by the author. We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.
All articles published in Diagnostic Pathology are included in PubMed, the most widely used biomedical bibliographic database service, which is run by the US National Library of Medicine. Other bibliographic databases that index articles published in Diagnostic Pathology include:
- Current contents
- Google Scholar
- PubMed Central
- Science Citation Index Expanded
The full text of all research articles is deposited in PubMed Central, the US National Library of Medicine's full-text repository of life science literature, and other digital archives including e-Depot (The Netherlands).
The full text of all research articles published by BioMed Central is also available on SpringerLink.
Diagnostic Pathology is tracked by Thomson Reuters (ISI) and has an Impact Factor of 2.60.
Publication and peer review process
Criteria for publication
Diagnostic Pathology considers the following types of articles:
- Research: reports of data from original research.
- Reviews: comprehensive, authoritative, descriptions of any subject within the scope of the journal. These articles are usually written by opinion leaders that have been invited by the Editorial Board.
- Book reviews: short summaries of the strengths and weaknesses of a book. They should evaluate its overall usefulness to the intended audience.
- Case reports: reports of clinical cases that can be educational, describe a diagnostic or therapeutic dilemma, suggest an association, or present an important adverse reaction.
- Commentaries: short, focused and opinionated articles on any subject within the scope of the journal. These articles are usually related to a contemporary issue, such as recent research findings, and are often written by opinion leaders.
- Database articles: describe a new database or a substantial improvement of an existing database.
- Debate articles: present an argument that is not essentially based on practical research. Debate articles can report on all aspects of the subject including sociological and ethical aspects.
- Hypotheses: short articles presenting an untested original hypothesis backed solely by previously published results rather than any new evidence.
- Letter to the Editor: these can take three forms: a substantial re-analysis of a previously published article, a substantial response to such a re-analysis from the authors of the original publication, or an article that may not cover 'standard research' but that may be relevant to readers.
- Methodology articles: present a new experimental method, test or procedure. The method described may either be completely new, or may offer a better version of an existing method.
- Short reports: brief reports of data from original research.
- Software articles: describe the source code for software applications, tools or algorithm implementations. Typically, an archive of the source code of the current version of the software should be included with the submitted manuscript as a supplementary file.
- Study protocols: describe proposed or ongoing research, providing a detailed account of the hypothesis, rationale, and methodology of the study.
Manuscripts submitted to Diagnostic Pathology will be evaluated initially by the Editor-in-Chief, who may decline it, choose appropriate reviewers from the Editorial Board or from outside, or assign it to a Section Editor for review. The Section Editor will recruit at least two members of the Editorial Board to give comments, and can call upon outside experts should s/he feel the need.
Based on these reviews a recommendation will be made for rejection, revision or acceptance; the final decision lies with the Editor-in-Chief. It is expected that the review period will not exceed three weeks. Rejected works are permitted one additional round of re-submission. If the resubmitted work is declined again, the decision is final.
Authors will be able to check the progress of their manuscript through the submission system at any time by logging into My Diagnostic Pathology, a personalized section of the site.
High-quality, bound reprints can be purchased for all articles published. Please see our reprints website for further information about ordering reprints.
Diagnostic Pathology will consider supplements based on proceedings (full articles or meeting abstracts), reviews or research. All articles submitted for publication in supplements are subject to peer review. Published supplements are fully searchable and freely accessible online and can also be produced in print. All full length articles (proceedings, reviews or research articles) are indexed by PubMed. PubMed displays the title of the supplement only in the case of meeting abstract collections. For further information, please contact us.
All manuscripts submitted to Diagnostic Pathology should adhere to BioMed Central's editorial policies.
Citing articles in Diagnostic Pathology
Articles in Diagnostic Pathology should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.
Article citations follow this format:
Authors: Title. Diagn Pathol [year], [volume number]:[article number].
e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Diagn Pathol 2009, 1:115.
refers to article 115 from Volume 1 of the journal.
Why publish your article in Diagnostic Pathology?
Diagnostic Pathology's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience. Articles that have been especially highly accessed are highlighted with a 'Highly accessed' graphic, which appears on the journal's contents pages and search results.
Speed of publication
Diagnostic Pathology offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF; the article will then be available through Diagnostic Pathology, BioMed Central and PubMed Central and will also be included in PubMed.
Online publication in Diagnostic Pathology gives authors the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).
Promotion and press coverage
Articles published in Diagnostic Pathology are included in article alerts and regular email updates. Some may be included in abstract books mailed to academics and are highlighted on Diagnostic Pathology's pages and on the BioMed Central homepage.
In addition, articles published in Diagnostic Pathology may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Diagnostic Pathology. A list of articles recently press-released by journals published by BioMed Central is available here.
Authors of articles published in Diagnostic Pathology retain the copyright of their articles and are free to reproduce and disseminate their work (for further details, see the BioMed Central copyright policy and license agreement).
For further information about the advantages of publishing in a journal from BioMed Central, please click here.